Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
8 Clinical Investigation Detection of Enterovirus RNA in Myocardial Biopsies From Patients With Myocarditis and Cardiomyopathy Using Gene Amplification by Polymerase Chain Reaction Ou Jin, MD, Michael J. Sole, MD, Jagdish W. Butany, MD, Wah-Kiam Chia, MSc, Peter R. McLaughlin, MD, Peter Liu, MD, and Choong-Chin Liew, PhD Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 Recent molecular studies have suggested that viral myocarditis frequently underlies human congestive cardiomyopathy; however, only moderately sensitive and specific techniques were used. Polymerase chain reaction (PCR) gene amplification is a sensitive, specific technique ideally suited for the diagnosis of viral disease in small tissue samples where low copy numbers of the viral genome may be present. Using PCR and high stringency condition, we screened biopsies taken from 48 patients with clinically suspected myocarditis or dilated cardiomyopathy. Five patients demonstrated positive enteroviral signals by PCR; two of them had myocarditis by pathology, whereas the other three had changes consistent with cardiomyopathy. Four other patients had myocarditis diagnosed by pathology from 3 months to 1 year earlier but were now negative by both PCR and pathology. Both pathology and PCR were negative for active myocarditis in all other patients. Ventricular samples taken from left ventricular myectomy in four additional patients with hypertrophic cardiomyopathy, normal human ventricle samples, and uninfected monkey kidney cells were also negative by PCR. This study supports a link between viral infection and dilated cardiomyopathy in some patients. PCR gene amplification provides a new diagnostic approach to patients with suspected myocarditis. (Circulation 1990;82:8-16) E- nteroviruses, particularly the coxsackievi- believed to be the most common viral agents for the pathogenesis of human myocarditis.' Although serological studies have indicated an association of coxsackievirus B viral infection with myocarditis,2-5 viral cultures of myocardial tissue obtained by endomyocardial biopsies from patients with biopsy-proven myocarditis or dilated cardiomyopathy are almost always negative, even when the clinical history or serological studies indicate recent viral infection.67 In addition, immunocytochemical studies of myocardial tissue have ruses, are From the Laboratory of Molecular Cardiology, Departments of Medicine, Clinical Biochemistry, Pathology, and Microbiology, The Centre for Cardiovascular Research, The Toronto Hospital, University of Toronto, Ontario, Canada. Supported by grants from the Medical Research Council of Canada and the Heart and Stroke Foundation of Ontario. M.J.S. is a Distinguished Research Professor of the Heart and Stroke Foundation of Ontario. P.L. is a Research Scholar of the Heart and Stroke Foundation of Ontario. Address for correspondence: Dr. Michael J. Sole, Room 13-208 EN, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada. Received October 4, 1989; revision accepted February 27, 1990. repeatedly failed to demonstrate the presence of viral antigens in patients with myocarditis and chronic dilated cardiomyopathy.8 Recombinant DNA technology holds great promise for the study of virus-associated myocarditis by detecting the presence of the viral genome in endomyocardial biopsy tissue. The molecular genetics of the enteroviruses, particularly coxsackievirus, and poliovirus, are well documented. The sequences of coxsackievirus Bi, B3, and B4 (CVB1, CVB2, and See p 294 CVB3) and poliovirus 1, 2, and 3 (PV1, PV2, and PV3) have been reported.9 12 Using coxsackievirus B complementary DNA (cDNA) probes, two groups have reported the presence of CVB2 and coxsackieviru's B4 (CVB4) signals in myocardial biopsies from patients with myocarditis or dilated cardiomyopathy using slotblot and in situ hybridization techniques.13'14 In these studies, nonspecific hybridization was a concern. Polymerase chain reaction (PCR) gene amplification is a technique that allows rapid and substantive amplification of specific DNA sequences. This sensi- Jin et al Enterovirus RNA in Myocardium tive and specific technique is ideally suited to the diagnosis of viral disease where low copy numbers of the viral genome may be present. In this study, we report the application of PCR gene amplification to the diagnosis of viral myocarditis using cardiac biopsies taken from 48 patients with clinically suspected myocarditis or dilated cardiomyopathy. Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 Methods Preparation of Coxsackievirus B RNA African Green monkey kidney cell culture in a concentration of 106 cells/ml and suspended in medium 199 containing 10% fetal calf serum and antibiotics was supplied by Connaught Laboratories, Toronto, Ontario. This cell suspension was seeded in 25-cm2 tissue culture flasks and incubated at 370 C for 24 hours. The medium was then replaced with minimum essential medium (MEM) supplemented with 10% fetal calf serum, penicillin (100 units/ml), streptomycin'(100 ,gg/ml), and fungizon (2.5 ,ug/ml). The cell culture flasks were further incubated at 370 C until a confluent monolayer of cells was observed before viral inoculation. Cell cultures were inoculated with CVB3 at a total titer of' 106 particles or 50% tissue culture infection dose (106 TCID50). After a 1-hour incubation at room temperature, the infected cell culture was washed twice with MEM and then incubated in 5.0 ml MEM containing antibiotics without fetal calf serum at 370 C. The infected cell culture monolayer was examined daily for 25-50% cytopathic effect. The cells were then suspended in 0.5 ml of 8 M guanidine-HCl (pH 5.0), passed twice through a 25-gauge needle, and precipitated with one-half volume of ethanol at -20° C overnight. The precipitate was dissolved in autoclaved H2O, and the RNA was quantified by ultraviolet spectrophotometry. Myocardial Biopsies and Histopathology Right ventricular endomyocardial biopsy samples were obtained from 48 patients with a Stanford bioptome by the internal jugular approach.15 Five samples were usually taken from each patient, and four were fixed in 10% formalin, embedded in paraffin, and cut into 4-5-gm sections; one section (usually less than 1 mg) was instantly frozen in liquid nitrogen for molecular diagnosis. Multiple sections of the biopsy were stained with hematoxylin and eosin and examined by light microscopy. Each section was studied in detail, and the diagnosis of myocarditis was based on the Dallas criteria.16 Myocardial biopsy samples for study by PCR were homogenized with 0.5 ml of 8 M guanidine-HCl (pH 5.0) in a small homogenizer and spun down to remove tissue debris. Total nucleic acids were then precipitated with ethanol, dissolved in 15 gul of autoclaved H20, and prepared for further assay. 9 Blood DNA Isolation The procedure for rapid DNA isolation from blood was a modification of the method described by Lindblom et al.17 Blood samples (5 ml) were lysed with cold sucrose buffer (10 ml, pH 7.5, 1% Triton X-100 in 320 mM sucrose, 1 mM Tris-HCI, and 5 mM MgCl2). After centrifugation (2,000 g at 40 C for 20 minutes), the pellet was resuspended in the same buffer and incubated in proteinase K (500 ,ug/ml, fresh stock solution: 1 mg/ml in 1% sodium dodecyl sulfate [SDS] 2 mM EDTA [pH 8.0]). Proteins were extracted by the addition of the same volume of Tris-EDTA-saturated phenol: chloroform: isoamyl alcohol (25:24: 1). After centrifugation (10,000 g at 40 C for 10 minutes), the upper aqueous phase was transferred to a new tube, and DNA was precipitated by adding 2 vol of absolute ethanol (200 C for 2 hours or longer). The DNA was dissolved in sterilized H O and quantitated by ultraviolet spectrophotometry. Oligonucleotide Synthesis and Labeling Oligonucleotides (20-60 base pairs) were prepared by a solid-phase phosphotriester method18 and labeled at the 5' end with phosphorus-32-r-ATP (specific activity, 3,000 Ci/mmol, New England Nuclear, Boston, Mass.). Oligonucleotide (0.6-1 jug) was incubated in standard kinase buffer'6 plus 150 ,uCi "2P-r-ATP and 10 units polynucleotide kinase (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) in 50 ,lI total volume for 1 hour at 370 C. Labeled oligonucleotide was separated from unincorporated ATP by passage through a G-50 column (Pharmacia, Sweden) in 10 mM Tris-HCl (pH 7.5) and 0.1 mM EDTA. The specific activity of the probes was 7-8 x 107 cpm/,g. Viral cDNA Synthesis and PCR Gene Amplification First strand cDNA synthesis. We synthesized the first strand cDNA using a virus-specific primer (see Figure 1). Four microliters (0.5 ,tg) of kidney cell RNA and 15 ,l of biopsy RNA samples (RNA heated to 700 C for 5 minutes before synthesis) were added to 40 ,ul of 500 mM Tris-HCl (pH 8.3), 500 mM KCl, 100 mM MgCl2, 10 mM 1,4-dithiothreitol (DTT), 10 mM EDTA, 100 gg/ml bovine serum albumin (BSA), 80 mM sodium pyrophosphate, 10 mM spermidine-HCI, 10 mM deoxynucleotide triphosphates (dNTP), and 100 ,ug/ml oligo d(T),"2-18 1 ,uM of each primer, and 1,000 units/ml avian murine virus (AMV) reverse transcriptase. These mixtures were incubated at 420 C for 50 minutes and then at 650 C for 10 minutes to denature the AMV reverse transcriptase. The samples were then ready for PCR gene amplification. PCR gene amplification. Two microliters (0.025 ,ug) of both uninfected and infected cell samples and 20 ,u1 of biopsy samples containing the first strand cDNA as described above were added to 40 gl of 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCI,, 0.01% (wt/vol) gelatin, 200 ,uM each deoxynucleo- Circulation Vol 82, No 1, July 1990 10 Probe 1 0 5' Probe 2 'S 3' 200 cDNA 600 400 I Primer A 5' Primer B i 3r Primer C 3P * (-) strand B 750 | 3' 3' 5' Viral RNA 3' 3' Denature Denature - Primer D Anneal to Anneal primer A Probe 1 3'--GCGATCGTGAGACCATTAGTGCCATGGAAACACGCGGACAMAA TATGGGGGAGGGGGTTGA--5' Primer A: 5'--AGCCTGTGGGTTGATCCCAC--3' Primer B: 3'--CTAGTTGTCAGTCGCACCGT--5' METHOD 2 Probe 2: 3'--CAGCATTGCCCGTTGAGACGTCGCC1TGGCTGATGAAACCCA CAGGCACAAAGTAATA--5' Primer C: 5'--TCCTCCGGCCCCTGAATGCG--3' Primer D: 3'--ACCGACGAATACCACTGTTA--5' Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 FIGURE 1. Sequences of synthetic oligonucleotide primers and probes and their relation to the target enterovirus genomic RNA (positive strand) region. Primers A and C are complementary to the negative strand, and primers B and D are complementary to the positive strand. Probes 1 and 2 are complementary to the coxsackievirus genomic RNA. tide triphosphates, and 1 /LM of each primer (Perkin-Elmer-Cetus protocol). After 10 minutes at 940 C, 5 units of Taq polymerase (Stratagene, La Jolla, Calif.) and 80 gl mineral oil were added, and PCR cycles were started (denaturation: 1 minute at 900 C; annealing: 2 minutes at 520 C; elongation: 3 minutes at 720 C). Blot Hybrdization After PCR gene amplification, the products (40 ,tl each) were added to 120 ,l of a solution of 6.15 M formaldehyde and lOx SSC (same as cDNA control: 2 ,ul of uninfected cell, and infected cell and 20 gl of biopsy cDNA, respectively, with dH2O added to 40 ,ul). These mixtures were incubated for 15 minutes at 650 C. The denatured samples were loaded onto a Schleicher and Schuell Minifold IL Slot Blot apparatus (containing a nitrocellulose filter that had been soaked in water) with suction. Each sample well was washed with 200 ,ul of lOx SSC. The nitrocellulose sheets were vacuum-dried for 2 hours at 800 C. Filters were prehybridized in 6 x SSC, 5 x Denhardt's solution (0.1% Ficoll, 0.1% BSA, 0.1% polyvinylpyrrolidone,19 0.5% SDS, and 100 ,gg/ml sheared salmon sperm DNA) at 550 C for at least 2 hours. After prehybridization, a second hybridization was performed with the prehybridization solution except that approximately 1 x 107 cpm of radiolabeled probe was added. After 8-16 hours at 55° C, filters were rinsed in 6x SSC and 0.1% SDS at room temperature, washed in 3x SSC and 0.1% SDS for 15 minutes at 550 C twice and 65° C for 5-10 minutes, and autoradiographed at -70° C for various times with intensifying screens. primer C Extension Extension METHOD 1 to p R (- strand |B Denature Annealing (Primer A and B) Extension C () strand | Denature Annealing (Primer C and D) Extension Repeat Cycles Schematic representation of the PCR protocol FIGURE 2. Schematic representation of the PCR protocol demonstrating virus-specific complementary (cDNA) synthesis from enteroviral RNA by reverse transcriptase and PCR gene-amplification procedure (see "Methods"). Results Enteroviruses exhibit areas of extensive nucleotide sequence homology even between disparate members such as the coxsackievirus and polioviruses. Other regions are virus specific. Using virus-specific primers (see Figure 1) to synthesize specific regions of cDNA, we could select primer pairs that would amplify sequences of a broad range of enteroviruses. The regions between these pairs could then be identified by probes exhibiting homologies to specific viruses or to the broad family. The sequence of synthetic oligonucleotide primers and probes and their relation to the target enterovirus region is shown in Figure 1. Comparison of probes 1 and 2 to CVB1, CVB3, CVB4, PV1, PV2, and PV3 revealed that probe 1 is most homologous with CVB3. Primers A and B are most homologous to CVB3, whereas primers C and D have 100% sequence homology with six viruses (CVB1, CVB3, CVB4, PV1, PV2, and PV3). Probe 2 exhibits more than 96% homology with CVBl, CVB3, and CV4 and more than 90% with PV1, PV2, and PV3. Therefore, probe 2 is more group specific for the enteroviruses than probe 1. Overall, both primers and probes should allow detection of the presence of either coxsackievirus and poliovirus families. Figure 2 briefly describes the method used to synthesize cDNA from enteroviral RNA derived from either infected culture kidney cells or biopsies by reverse transcriptase and PCR gene amplification. Jin et al Enterovirus RNA in Myocardium .a b 2 3 X~~~~~~~~~~~~~~~~~~~.... i.. Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 4 ... 8 _ 11 c FIGURE 3. Slot-blot hybridization of probe 1 (coxsackievirus B3 [CVB3]) to different samples: 1) cells infected with CVB3 (1.5 gg), 2) cells infected with CVB6 (1.5 gg), 3) uninfected cells (1.5 gg), 4) biopsy A, 5) biopsy B, 6) biopsy C, 7) biopsy D, 8) normal blood DNA (1.5 ag), and 9) normal total human ventricular RNA (1.5 gg). Isolation method of biopsies B, C, and D is the same as biopsy A and 48 other patients except cell debris was not removed. Amount of RNA could not be quantitated due to minute size of the biopsy samples. This filter was hybridized with CVB3specific oligonucleotide probe 1 at 550 C and washed with 3 x SSC and 0.1% sodium dodecyl sulfate buffer at 1) room temperature for 5 minutes and 550 C for 15 minutes, 2) 550 C for 15 minutes and 65° C for 10 minutes, and 3) 650 Cfor 60 minutes. 9 _ EvL initial experiments, we did not use PCR amplification but instead used a conventional method in which synthetic oligonueleotides derived from coxsackievirus sequences served as diagnostic probes.13 Figure 3 shows the results of slot-blot analysis of four biopsy samples by the conventional method. Biopsy sample A was from a patient whose clinical diagnosis indicated myocarditis with severe left ventricle dysfunction and who had myocarditis and pericarditis by pathology. Biopsy B was from a patient who had ventricular tachyarrhythmias after myocardial infarction a few weeks earlier but showed no evidence of coronary disease by coronary angiography and pathology. Biopsies C and D were from two patients whose clinical diagnoses indicated dilated cardiomyopathy and whose pathology indicated changes compatible with congestive cardiomyopathy but showed no evidence of myocarditis. The cell debris was not removed from biopsies B, C, and D after guanidine-HCI homogenation, whereas the cell debris from sample A was removed. After RNA precipitation, all four samples were dissolved in 30 gl autoclaved H20 and subjected to slot-blot analysis. From these experiments, it is clear that crosshybridization exists between viral RNA and human DNA and RNA, leading to false-positive results under low stringency conditions and negative results In gene our under higher stringency conditions. To improve both the sensitivity and specificity, we used PCR geneamplification methodology in subsequent studies. Figure 4 shows the sensitivity and specificity of probe 1, primer A, and primer B after 30 PCR cycles. It indicates that virus-specific primer was better than oligo d(T) for synthesizing specific eDNA in 5' region. Because the CVB3 genome is 7.5 kb in length, it will be difficult to synthesize a full-length eDNA. Figure 5 shows the results of agarose gel electrophoresis and oligonucleotide hybridization analysis of PCR-amplified DNA samples from monkey kidney cells. A single band is present, migrating at 184 bp in DNA from infected cells but not from uninfected cells. This result also demonstrates the sensitivity and specificity of the PCR gene-amplification method. Figure 6 shows a typical PCR analysis of Enterovirus RNA from endomyocardial biopsy samples using probe 2, primer C, and primer D. Like other patients whose data are presented in Table 1, the cell debris was removed before slot-blot analysis. Negative and positive controls were used for each experiment. Unlike conventional slot-blot analysis, PCR analysis does not reveal a continuum of hybridization signal intensity. Signals were either positive or absent. Among 48 patients screened by PCR gene amplification, probe 1, primer A, and primer B were used Circulation Vol 82, No 1, July 1990 12 AftXer. Before ......iEE: ..... ....... .... .... ...... .. ..... ... EEEE E ..-.... iRRRiSE ES. E-! EEE--EERE ... ...... ...... .EEREE .......iEER EE ..E .... *E E---;E SE ......--. .E .. ..... ...... 5 (i ........ EEEEE ....... *......... :.EEREREEEE; -f----gE- iEEREEER .......dER:::Z ............ iEEEEEE--li ............R :.sf ...........: .........::E FIGURE 4. Assessment of the sensitivity and specificity .E RE .EEEiR.E......i..... iR ......... E.fit EE..iRiR ... RR.......! d-. ER fi- ...........Ej EEE ....: .E ...... .EREit eEERR.f ....... t. ....0iEER s-E 300 of probe 1, primer A, and primer B after 30 polymerase chain reaction (PCR) cycles: 1) uninfected cells + oligo d(T)12 18 primer, 2) cells infected with coxsackievirus B3 4:ii< (CVB3) + oligo d(T)12 18primer, 3) uninfected cells + CVB3 specific primers A and B, and 4) cells infected with CVB3 + CVB3-specific primers A and B. For infected cells, the total RNA was isolated when 25% of cells showed cytopathic effect by infection of CVB3: 5) uninfected cells + oligo d(T)12 18primer, 6) cells infected with 6 CVB3 + oligo d(T)f2l8 primer, 7) uninfected cells + CVB3-specificprimersA anzd B, and 8) cells infected with 7 CVB3 + CVI33-specific primers A and B. For infected cells, the total RNA was isolated when 50% of cells showed cytopathic effect by infection of CVB3. cDNA, 8 complementwy DNA. !EE.......... RiREE*i- Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 ....... :.. tEE :3out ..... .....E ....s; .E .EE Rf ERtE .. ...... R:: in patient samples 1-7, lla, 14, iSa, and 16. Probe 2 and primers C and D were used in all other patients, including llb, 15b, and 15c. Five patients (14-16, 29, and 42) contained enterovirus RNA in myocardial tissue as shown by PCR gene amplification. A biopsy from one of these patients (patient 15) 3 months later continued to be positive. However, a third biopsy 4 months later was negative. The results derived from PCR analysis were correlated to the pathological results (see Table 1). In two patients (15 and 42), both PCR analysis and pathology indicated the presence of myocarditis. Three patients (14, 16, and 29) with congestive cardiomyopathy but not active myocarditis as indicated by pathology exhibited definite viral signals by PCR. Four patients (1, 8, 11, and 19) with myocarditis by pathology 3 months to 1 year earlier had a negative PCR result and no evidence of myocarditis by pathology when examined during this study. PCR analysis was performed using blood from one of these patients (15a), but no viral RNA was indicated. Samples were taken from the left ventricle in four additional patients with hypertrophic obstructive cardiomyopathy, from normal human ventricles, and from uninfected monkey kidney cells (not shown). No viral RNA was indicated by PCR analysis in these tissues. Discussion The genomic sequence relation of the enteroviruses such as CVB1, CVB3, CVB4, PV1, PV2, and PV39-12 allow the introduction of methods using synthetic oli- Jin et al Enterovirus RNA in Myocardium E ..: I :. 2 Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 FIGURE 5. Agarose gel electrophoresis 1) of amplified coxsackievirus B3 (CVB3) sequence fragment by polymerase chain reaction (PCR) after 40 cycles with probe 1, primer A, and primer B. Lane 1: Uninfected cells. Lane 2: Infected cells (by CVB3). These samples were run on 3% Nusieve/1% agarose in 1 xtris-HCI acetate EDTA buffer. Southern blot hybridization analysis 2) of PCR-amplified fragments of CVB3 genome from infected cells. -:184 bp (1) gonucleotides, which are CVB- and Enterovirus-specific for the detection and analysis of viral genomic RNA sequence. These probes, used in conjunction with PCR technology, are particularly well suited to the diagnosis of viral infections of heart tissue because myocardial biopsies are of limited size and the viral RNA copy number in cardiac cells is probably very low. PCR is a unique in vitro gene-amplification method that can produce a greater than 105-fold increase in the amount of target sequence, permitting analysis of as little as 1 ng of genomic DNA.211 The enteroviral genome is a single-stranded, positive-sense RNA molecule.21 Available sequence data allowed us to choose a viral region that would exhibit homology to a broad range of enteroviruses in a sensitive and specific manner. We screened 48 patients with clinically sus- 13 (2) pected myocarditis and cardiomyopathy with this method; only five patients exhibited an enteroviral genome in their myocardium. One of our patients presented with a postpartum cardiomyopathy; however, her endomyocardial biopsy revealed active myocarditis by pathological examination. It is of interest to note that when this patient was examined 3 months later, pathology was negative for myocarditis, but the PCR result was still positive. Four months later, both pathology and PCR produced negative results. This case demonstrates that viral myocarditis can be the underlying etiology of some cases of postpartum cardiomyopathy. Three other patients had biopsies that were positive by PCR analysis. These patients had clinically manifested cardiomyopathy and exhibited negative 14 Circulation Vol 82, No 1, July 1990 Before PCR (cDNA) After PCR 26 27 28 Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 29 30 31 32 33 34 35 15c Uninf Cell lnf Cell (CVB3) FIGURE 6. Examples of polymerase chain reaction (PCR) analysis of Enterovirus RNA in endomyocardial biopsy samples. cDNA, complementary DNA; CVB3, coxsackievirus B3. (50 cycles) pathology by the Dallas criteria but had histories suggestive of myocarditis. Although the pathology indicated no evidence of active myocarditis, there was a significant amount of fibrosis and myocyte hypertrophy present, suggesting considerable myocardial damage due possibly to myocarditis. In contrast to the PCR gene-amplification results, conventional slot-blot hybridization failed to exhibit a viral signal with coxsackievirus probes under stringent conditions in each of these four patients. Thus, in these patients, the level of viral RNA was less than the limit of conventional detection or the viral genome was incomplete, possibly accounting for the failure to isolate infectious progeny virus or to demonstrate the presence of virus-specific antigens from biopsy samples in previous studies. These results suggest that residual viral genome may be present in myocardial cells in the absence of acute, pathologically manifest myocarditis and may predispose such individuals to ensuing dilated cardiomyopathy. It is also possible that the ditference between pathology and PCR evaluation is a manifestation of sampling heterogeneity and that the biopsy samples analyzed by hybridization may have exhibited pathologically evident myocarditis had they been subjected to microscopy. One of our patients was an 18-year-old woman who had symptoms of myocarditis and a positive pathological diagnosis on her first biopsy that showed evidence of an inflammatory infiltrate and scattered muscle fiber necrosis. Unfortunately, her initial biopsy sample was not available for PCR. Six months later when a tissue sample was Jin et al Enterovirus RNA in Myocardium 15 TABLE 1. Detection of Enteroviral RNA Sequences in Myocarditic Human Heart Biopsies by Polymerase Chain Reaction Technique Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 Patient 1 3 5 8 9 10 lla llb 12 14 15a 15b 15c 16 19 29 Clinical diagnosis Myocarditis Myocarditis Myocarditis Myocarditis Myocarditis Myocarditis fibrosis Myocarditis, CMP Myocarditis, CMP CMP Myocarditis, CMP Postpartum CMP Postpartum CMP Postpartum CMP Myocarditis, CMP Myocarditis Myocarditis 30 31 32 39 40 41 42 43 46 47 48 17, 20, 21, 22, I 23, 26, 27, 34, 35 J Myocarditis Myocarditis Myocarditis Myocarditis Myocarditis 2,4,6, 7,13, 18, 24, 25, 28, 33, 36, 37, 38, J Myocarditis Myocarditis Myocarditis Myocarditis Myocarditis Myocarditis Pathology result Dilated CMP (myocarditis by biopsy 1 year earlier) Interstitial vessels show luminal stenosis Mild interstitial fibrosis Mild, focal interstitial fibrosis (myocarditis by biopsy 4 months earlier) Right ventricular dysplasia Mild interstitial Congestive CMP (myocarditis by biopsy 4 months earlier) Myocarditis Pompe's disease Congestive CMP Active myocarditis No evidence of active myocarditis No evidence of active myocarditis Congestive CMP Mild, focal interstitial fibrosis (myocarditis by biopsy 1 year earlier) Dilated CMP (moderately severe interstitial fibrosis; focal mild increase in interstitial mononuclear cells) Increased adipose tissue, possible right ventricular dysplasia Active myocarditis (1 week after onset of herpes zoster) Hypertrophic CMP (Becter's muscular dystrophy) Mild subendocardial fibrosis Patchy mild interstitial fibrosis Patchy muscle fiber hypertrophy Focal myocarditis Presence of amyloid (on special stains) Tissue inadequate for diagnosis Patchy endocardial and interstitial fibrcOSiS Significant iron overload Myocarditis Normal Myocarditis Dilated CMP PCR result + + 44, 45 PCR, polymerase chain reaction; CMP, cardiomyopathy; -, negative; +, positive. available for analysis by PCR, it was negative. Although pathology revealed no active myocarditis, there was myocyte destruction and fibrosis consistent with clinical congestive cardiomyopathy. This patient went for a heart transplant in October 1988 due to severe dilated congestive cardiomyopathy but subsequently died. Her myopathic heart was available for detailed hybridization study with different enteroviral primers and probes, but although pathology exhibited areas of myocarditis, PCR analysis was consistently negative. One possible explanation was that the free viral RNA in the myocardium had degraded despite the relatively rapid RNA isolation because the heart was not immediately frozen. Another patient, a 50-year-old woman, who had a sudden onset of pulmonary edema after the onset of herpes zoster infection 1 week earlier, showed active myocarditis by pathology but no enteroviral signal by PCR. Myocarditis in this case may have been due to infection by herpes virus rather than an enterovirus. Three other patients had a definite history and biopsyderived evidence of myocarditis; however, when biopsied 3 months to 1 year later, both pathology and PCR analyses were negative. The negative PCR and pathological data in these cases could be due to sampling heterogeneity. Furthermore, although we used primers and probes designed to capture most enteroviruses, there are other viral families that can cause viral myocarditis. 16 Circulation Vol 82, No 1, July 1990 Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 We also took blood samples from 14 patients to determine the usefulness of PCR analysis during theoretical viremia. All blood studies were negative for viral signals, including a sample from one patient (15) whose heart biopsies were positive by both PCR and pathology. This study supports a link between Enterovirus infection and congestive cardiomyopathy in some patients. However, the frequency of Enterovirus-like RNA sequences in clinically suspected myocarditis and cardiomyopathy samples is not as high as reported by others using slot-blot hybridization without PCR or in situ hybridization.1314 Sampling has been a major impediment to the pathological diagnosis of myocarditis from biopsy analysis. It is estimated that 17.2 samples are required per patient for 79% diagnostic sensitivity; such sample numbers are clinically unattainable.22 Although sampling heterogeneity may account for differences between PCR studies and those using standard hybridization techniques, it is unlikely to account for a difference of this magnitude. It would seem more likely that homologies between human DNA and RNA and viral sequences led to false-positive results under conditions that were not highly stringent. In conclusion, this study supports a link between viral infection and dilated cardiomyopathy in some patients. It appears that the number of viral RNA copies present in myocardial cells from human myocarditis hearts is very low; however, the PCR gene-amplification method can provide a very sensitive and specific means for the study of such tissue. 6. Daly K, Richardson PJ, Olsen EGJ, Capner PM, Mcsorley C, Jackson G, Jewitt DE: Acute myocarditis: Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J 1984;51:30 7. Parrillo JE, Aretz HT, Palacios I, Fallon JT, Block PC: The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 1984;69:93 8. Rose AG, Beck W: Dilated (congestive) cardiomyopathy: A syndrome of severe cardiac dysfunction with remarkably few morphological features of myocardial damage. Histopathology 1985;9:367 9. lizuka N, Kuge S, Nomoto A: Complete nucleotide sequence of the genome of coxsackievirus B,. Virology 1987;156:64-73 10. Lindberg AM, Stalhandske POK, Petterson U: Genome of coxsackievirus B3. Virology 1987;156:50-63 11. Jenkins 0, Booth JD, Minor PD, Almond JW: The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of picornaviridae. J Gen Virol 1987; 68:1835-1848 12. Toyoda H, Kohara M, Kataoka Y, Suganuma T, Omata T: Complete nucleotide sequences of all three poliovirus serotype genomes. J Mol Biol 1984;174:561-585 13. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC: Detection of coxsackie B virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;1 :1120 14. Kandolf R: The impact of recombinant DNA technology on the study of enterovirus heart disease, in Benclinelli M, Friedman H (eds): Coxsackievirus: A General Update. Plenum Publishing, 1988, pp 303-305 15. Richardson PJ: Endomyocardial biopsy technique and evaluation of a new disposable forceps and catheter sheath system, in Bolte HD (ed): Viral Heart Disease. Berlin, Springer-Verlag, 1984, pp 173-176 16. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenolio JJ Jr, Olsen EG, Schoen FJ: Myocarditis, a histopathologic definition and classification. Am J Cardiovasc Acknowledgments We are grateful to Mr. Jack Liew for synthetic oligonucleotides and Dr. Samuel Mok for technical assistance. We thank Sian Liem and Douglas Anderson for secretarial assistance. 17. Lindblom B, Holmlund G: Rapid DNA purification for restric- Pathol 1987;1:3-14 References 1. Woodruff JF: Viral myocarditis: A review. Am J Pathol 1980; 101 :427-529 2. Grist NR, Bell EJ: A six-year study of coxsackie B infection in heart disease. J Hyg (Lond) 1964;73:165-172 3. Koontz CH, Ray CJ: The role of coxsackie group B virus infection in sporadic myopericarditis. Am Heart J 1971;82:750 4. Schmidt NJ, Ma RL, Lennette EH: Association of group B coxsackieviruses with cases of pericarditis, myocarditis, or pleurodynia by demonstration of immunoglobulin M antibody. Infect Immun 1973;8:341-343 5. El-Hagrassy MMO, Banatvala JE, Coltart DJ: Coxsackie B virus specific IgM response in patients with cardiac and other diseases. Lancet 1980;2:1660-1662 tion fragment length polymorphism analysis. Gene Anal Tech 1988;5:97-101 18. Markham AF, Edge MD, Atkinson TC, Greene AR, Heatheliffe GR, Newton CR, Scanlon D: Solid phase phosphotriester synthesis of large oligonucleotides on a polyamide support. Nucleic Acids Res 1980;8:5193-5205 19. Denhardt DT: A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun 1966; 23:641-646 20. Saiki RK, Bugawan TL, Horn GT: Analysis of enzymatically amplified ,B-globin and HLA-DQa DNA with allele-specific oligonucleotide probes. Nature 1986;324:163-166 21. Wimmer E, Kuhn RJ, Pincus S. Yang CF, Toyoda H, Nickln MJH, Takeda N: Molecular events leading to picornavirus genome replication. J Cell Suppl 1987;7:251-276 22. Chow LH, Sears TD, Mcmanus BM: Insensitivity of right ventricular endomyocardial biopsy in the diagnoses of myocarditis. J Am Coll Cardiol 1989;13:253A KEY WORDS * dilated cardiomyopathy * coxsackievirus myocarditis * polymerase chain reaction * complementary DNA . Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. O Jin, M J Sole, J W Butany, W K Chia, P R McLaughlin, P Liu and C C Liew Downloaded from http://circ.ahajournals.org/ by guest on August 3, 2017 Circulation. 1990;82:8-16 doi: 10.1161/01.CIR.82.1.8 Circulation is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Copyright © 1990 American Heart Association, Inc. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circ.ahajournals.org/content/82/1/8 Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Circulation can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: http://www.lww.com/reprints Subscriptions: Information about subscribing to Circulation is online at: http://circ.ahajournals.org//subscriptions/